From the Editor-in-Chief: Issue at a Glance

In 2020 the US Surgeon General made a Call-to-Action to Control Hypertension on which we have already commented in the Journal.1 The current issue of the American Journal of Hypertension for March 2022 includes a Compendium on the US Surgeon General’s Call-to-Action to Control Hypertension comprising 5 articles. The Compendium is introduced by one of the Associate Editors of the Journal, Paul Muntner, who edited the Compendium, in which each of the 5 articles are described in more detail2 than here. The first of the Compendium’s articles is by Mayfield et al.3 and it deals on whether there will indeed be action in response to the call. The next article is by Colvin et al.4, which addresses how the US Surgeon General’s Call-to-Action may advance equity in blood pressure control. The following article by Tajeu et al.5 discusses cost-effectiveness of the Call-to-Action to Control Hypertension recommendations. In the article that follows, Commodore-Mensah et al.6 present the proceedings of a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention workshop to control hypertension. In the final article of the Compendium, Wall et al.7 wonder how to enhance self-measured blood pressure monitoring in the U.S. This present issue’s original articles start with one by Krousel-Wood et al.8 who assessed the association between preference for immediate gratification, low medication adherence, and uncontrolled blood pressure in adults with hypertension. The authors conclude that adults with preference for immediate gratification have worse adherence. The low adherence partially mediated the association of high discount rate with uncontrolled blood pressure. The next original manuscript is an evaluation of cardiac health in the spontaneously hypertensive rat and its implications of evolutionary driven increases in concentric hypertrophy by Holjak et al.9 The authors questioned whether the hypertension-induce sequelae of heart failure in the SHR have remained stable after decades of inbreeding. The study established that there has been a cardiac-based phenotypic shift in the SHR model. It also suggests that concentric hypertrophy may be beneficial in hypertension-induced heart failure. The following article by Spronck et al.10 evaluates the predictive ability of pressure-corrected arterial stiffness indices in a comparison of pulse wave velocity (PWV) and cardio-ankle vascular index (CAVI) in 154 subjects with and without heart failure. The findings of this study showed that BP-corrected arterial stiffness measurements were not better predictors of heart failure-related hospital admission than conventional arterial stiffness metrics. They did not predict heart failure-related hospital admission independently of systolic BP and support PWV as the primary arterial stiffness parameter for outcome prediction. The final article in the present issue of the Journal is by Nicoli et al.11 These authors examined whether neurotensin was associated with risk of hypertension through measurement of its precursor, pro-neurotensin/neuromedin N (pro-NT/NMN) in the population of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Circulating levels of pro-NT/NMN among the 614 subjects who developed hypertension compared to the 1078 subjects who did not in a subcohort with complete results over 10 years of follow-up showed that baseline pro-NT/NMN was not associated with incident hypertension.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.